The antiviral fomivirsen was the first antisense therapy to be licensed by the FDA. It binds to a cytomegalovirus mRNA and is used to treat cytomegalovirus retinitis.
Credit: Fvasconcellos (1 January 2007)
The antiviral fomivirsen was the first antisense therapy to be licensed by the FDA. It binds to a cytomegalovirus mRNA and is used to treat cytomegalovirus retinitis.
Credit: Fvasconcellos (1 January 2007)